Filter
882
Text search:
pharmaceutical
regulations
Featured
Recommendations
72
New Publications
238
Language
Document type
No document type
420
Studies & Reports
183
Guidelines
147
Manuals
50
Strategic & Response Plan
50
Training Material
11
Fact sheets
10
Situation Updates
6
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
Kenya
48
Global
32
India
26
Western and Central Europe
26
Nigeria
25
Sierra Leone
23
South Africa
23
Ethiopia
20
Ghana
19
Uganda
19
Liberia
18
Nepal
18
Tanzania
18
Rwanda
17
Africa
15
Namibia
14
Zambia
13
Eastern Europe
13
Philippines
11
Indonesia
11
Bangladesh
11
Lesotho
10
Zimbabwe
9
Myanmar / Burma
9
Latin America and the Carribbean
9
Malawi
8
Ukraine
7
South–East Asia Region
7
Cambodia
6
Eswatini/ Swaziland
6
West and Central Africa
6
Senegal
5
Thailand
5
Botswana
5
Eastern Europe and Central Asia
5
Cameroon
4
Syria
4
East and Southern Africa
4
Western Pacific Region
4
Burkina Faso
3
Haiti
3
Pakistan
3
China
3
Mozambique
3
Brazil
3
Laos
3
Russia
3
Vietnam
3
Guinea
2
Congo, Democratic Republic of
2
Mali
2
Sudan
2
North Macedonia
2
Middle East and North Africa
2
Asia
2
Fiji
2
Tajikistan
2
Kyrgyzstan
2
Somalia
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Germany
1
Chad
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Peru
1
Serbia
1
El Salvador
1
Angola
1
Chile
1
Albania
1
Armenia
1
Canada
1
Timor Leste/ East Timor
1
Lithuania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
398
Key Resources
44
Clinical Guidelines
34
Public Health
27
Pharmacy & Technologies
24
Women & Child Health
15
Capacity Building
6
Toolboxes
AMR
138
Pharmacy
91
COVID-19
73
Mental Health
34
HIV
30
TB
29
Rapid Response
27
Planetary Health
18
Caregiver
17
Health Financing Toolbox
16
Ebola & Marburg
15
2.0 Rapid Response
15
Global Health Education
12
NTDs
12
Malaria
12
Conflict
10
NCDs
9
Specific Hazards
6
Disability
5
Polio
2
Natural Hazards
2
Zika
2
Cholera
1
Refugee
1
Economic Issues, Policies and Option for Action
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec
...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate
...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells
...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug
...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to
...
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emergence of multi-resistant bacteria is posing challen
...
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio
...
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication
programmes that targets human, animal and plant
...
Pandemic Influenza Risk Management
recommended
A WHO guide to inform & harmonize national & international pandemic preparedness and response
The main updates from the 2013 interim guidance are:
Alignment with other relevant United Nations policies for crisis and emergency management, and
Inclusion of the significant development in re
...
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release into the environment. The purpose of the document is to identify existing instruments and standards in
...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del
...
